Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombolytic Therapy vs Surgery for Obstructive Prosthetic Valve Thrombosis
NCT02243839Unknown
- Sponsor
- Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi
- Start
- Jan 2014
- Primary completion
- Aug 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of tissue-plasminogen activator in prosthetic valve thrombosis (PVT), sponsored by Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi. Primary endpoints: Thrombolytic Success at 10 days, Non-fatal Complications for Thrombolytic Therapy at 3 weeks and 1 more. Status: unknown.
02
Drugs
tissue-plasminogen activator
03
Conditions
prosthetic valve thrombosis (PVT)
Beyond the preview
Go deeper on NCT02243839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243839.